Participant inclusion criteria
dyspareunia, bleeding
POST-MENOPAUSAL BLEEDING, BLEEDING, DYSPAREUNIA, PATHOLOGY, VAGINA, INTERMENSTRUAL BLEEDING
The NCSP eligibility policy is that “anyone with a cervix or vagina who has ever been sexually active should be offered three-yearly cervical screening from age 25 to age 69.” For this study, people eligible for cervical screening in the 12-month study period, attending an implementation practice, and aged from 24.5 to 70.0 years are eligible to participate. This includes women who are due for screening (including up to six months before their screening due date), overdue for screening (four years or more since their last screening i.e. one year or more overdue) or who have never had screening.Symptoms raising the possibility of cervical pathology require investigation and diagnosis. Symptoms include post-coital bleeding, unexplained intermenstrual bleeding, any post-menopausal bleeding, unexplained, persistent, and unusual vaginal discharge, or unexplained persistent deep dyspareunia. Women meeting the eligibility criteria but who have symptoms may still have an HPV test.